MetaVia is trading 6.09% down at $1.62 after-hours on September 18, 2026, and no clear company-specific announcement, earnings release, or late-breaking catalyst was identified.
- The regular-session close was $1.73.
- Latest reported company news remains September 9 preclinical DA-1726 data, which predates the decline.
- Broader markets were mixed-to-positive and do not clearly explain the move.